AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
54 hedge funds and large institutions have $11.3M invested in Asterias Biotherapeutics Inc. Series A in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $163K
Holders
54
Holding in Top 10
1
Calls
–
Puts
$163K
Top Buyers
| 1 | +$127K | |
| 2 | +$69.3K | |
| 3 | +$53.1K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$29.4K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$26.9K |
Top Sellers
| 1 | -$988K | |
| 2 | -$194K | |
| 3 | -$165K | |
| 4 |
ECM
Element Capital Management
New York
|
-$142K |
| 5 |
Millennium Management
New York
|
-$103K |